Hansa Biopharma to present at Stifel Healthcare Conference

Hansa Biopharma, a biotechnology company based in Sweden, will present at the Stifel 2026 Healthcare Conference in New York on November 12. Maria Törnsén, Chief Operating Officer and President of US operations, is scheduled to deliver a corporate presentation during the event held at the Lotte New York Palace.

In addition to the presentation, the company’s Chief Financial Officer, Adam Cutler, will be in attendance to engage with conference participants. The event provides a venue for the company to update investors on its strategic priorities and operational developments within the healthcare sector.

Industry conferences remain a critical channel for biotechnology firms to maintain visibility among institutional investors and industry analysts. Hansa Biopharma has invited interested parties to arrange meetings with their management team during the event.